But after clinical trails showed its promising effects on weight loss, in 2021, the FDA approved semaglutide (Wegovy), a once-weekly injection, for weight loss in adults when used in combination with a healthy diet and routine exercise
Increasing payer support and reimbursement coverage, enabling broader patient access and long-term market growth Government Initiatives Supporting the Obesity GLP-1 Market As obesity is increasingly recognized as a chronic, high-burden disease, government initiatives are playing a key role in supporting the obesity GLP-1 market
If you already have experience with GLP-1 injections and know what to expect from the medication, Peak Wellness's streamlined approach removes unnecessary friction
Johic got retatrutide from a med spa (which sourced it from a compounding pharmacy) after completing a questionnaire and a virtual consultation
The most common side effects include: Loss of appetite Nausea Vomiting Diarrhea Other side effects can include: Dizziness Increased heart rate Infections Headaches Upset stomach Although rare, there are some serious side effects, including: Pancreatitis (inflammation of the pancreas) Medullary thyroid cancer Kidney injury Worsening diabetes-related retinopathy (eye disease) What are the risks
Eli Lilly: What to know about retatrutide: An investigational triple hormone receptor agonist
